Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29992354 | 1.00 | PTGS2 (0.30) | PTGS2PTGS1 | |
| SCHEMBL20165779 | 0.91 | PTGS2 (0.32) | PTGS2PTGS1 | |
| SCHEMBL29874052 | 0.91 | PTGS2 (0.32) | PTGS2PTGS1 | |
| SCHEMBL14645995 | 0.90 | PTGS2 (0.30) | PTGS2PTGS1 | |
| SCHEMBL14645960 | 0.87 | PDE4B (0.34) | — | |
| SCHEMBL31355509 | 0.87 | — | — | |
| SCHEMBL31342807 | 0.87 | — | — | |
| SCHEMBL14645946 | 0.86 | TDO2 (0.32) | — | |
| SCHEMBL25865225 | 0.86 | — | — | |
| SCHEMBL25951024 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682201-A1 | BETA-NUCLEATED MULTIMODAL COPOLYMERS | Borealis GmbH (AT) | 2026-01-21 | — | — | EP | disclosed |
| EP-3820939-B1 | HETEROPHASIC POLYPROPYLENE COMPOSITION WITH IMPROVED BALANCE OF PROPERTIES | BOREALIS AG (AT) | 2024-06-05 | — | — | EP | disclosed |
| US-11981801-B2 | Polypropylene composition | BOREALIS AG (AT) | 2024-05-14 | — | — | US | disclosed |
| US-11807655-B2 | Catalysts | BOREALIS AG (AT) | 2023-11-07 | — | — | US | disclosed |
| US-11807655-B2 | Catalysts | BOREALIS AG (AT) | 2023-11-07 | — | — | US | disclosed |
| CN-113474406-B | Nucleated propylene polymer compositions with high toughness | 博里利斯股份公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230242748-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2023-08-03 | — | — | US | disclosed |
| CN-112424241-B | Catalyst | 博里利斯股份公司 | 2023-06-06 | — | — | CN | disclosed |
| US-11643427-B2 | Catalysts | BOREALIS AG (AT) | 2023-05-09 | — | — | US | disclosed |
| CN-112334532-B | Heterophasic polypropylene composition with improved balance of properties | 博里利斯股份公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-110741039-A | Polypropylene composition | 博里利斯股份公司 | 2020-01-31 | — | — | CN | disclosed |
| WO-2020011825-A1 | HETEROPHASIC POLYPROPYLENE COMPOSITION WITH IMPROVED BALANCE OF PROPERTIES | BOREALIS AG (AT) | 2020-01-16 | — | — | WO | disclosed |
| EP-3567060-A1 | PROCESS FOR PREPARING HETEROPHASIC PROPYLENE COPOLYMERS | Borealis AG (AT) | 2019-11-13 | — | — | EP | disclosed |
| EP-3562831-A1 | CATALYSTS | Borealis AG (AT) | 2019-11-06 | — | — | EP | disclosed |
| US-20190308995-A1 | CATALYSTS | BOREALIS AG (AT) | 2019-10-10 | — | — | US | disclosed |
| EP-3541823-A1 | CATALYSTS | Borealis AG (AT) | 2019-09-25 | — | — | EP | disclosed |
| EP-3456776-A1 | POLYPROPYLENE COMPOSITION | Borealis AG (AT) | 2019-03-20 | — | — | EP | disclosed |
| WO-2019012110-A1 | POLYPROPYLENE COMPOSITION | BOREALIS AG (AT) | 2019-01-17 | — | — | WO | disclosed |
| WO-2018122134-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-07-05 | — | — | WO | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190308995-A1 | CATALYSTS | SIGMAR1, H1-2, CBR1 | PTGS2 3756/4885PTGS1 3935/4885 |
| US-11807655-B2 | Catalysts | SOD1, MT-CO2, MT-CO1 | PTGS2 2491/4885PTGS1 3181/4885 |
| US-11643427-B2 | Catalysts | MLX, HAX1, CHRM1 | PTGS2 3439/4885PTGS1 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.